Volume 11 Issue 4
Jul.  2020
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2020  >  11(4): 482-486
Kou Jiantao, Liu Zhe, Zhu Jiqiao, et al. esearch on clinical efficacy of liver transplantation for severe liver disease[J]. ORGAN TRANSPLANTATION, 2020, 11(4): 482-486. doi: 10.3969/j.issn.1674-7445.2020.04.010
Citation: Kou Jiantao, Liu Zhe, Zhu Jiqiao, et al. esearch on clinical efficacy of liver transplantation for severe liver disease[J]. ORGAN TRANSPLANTATION, 2020, 11(4): 482-486. doi: 10.3969/j.issn.1674-7445.2020.04.010
shu

esearch on clinical efficacy of liver transplantation for severe liver disease

doi: 10.3969/j.issn.1674-7445.2020.04.010

  • Department of Hepatobiliary-pancreatic-spleen Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China

More Information
    Abstract
  •   Objective  To explore the clinical efficacy of liver transplantation for severe liver disease.  Methods  The clinical data of 51 patients who underwent liver transplantation for severe liver disease were retrospectively analyzed. The general intraoperative conditions were observed, including operation duration, warm ischemia time, cold ischemia time, anhepatic phase, bleeding volume, blood transfusion volume, plasma transfusion volume and so on. The changes in indexes such as total bilirubin (TB), prothrombin time activity (PTA), and prothrombin time international normalized ratio (PT-INR) were observed before operation and at 3 d, 1 week and 2 weeks after operation. The postoperative survival and occurrence of complications were analyzed. The indexes that might affect the prognosis of patients with severe liver disease were analyzed by Cox regression analysis.  Results  For the 51 patients, operation duration, warm ischemia time and cold ischemia time was 8 (7, 9) h, 3 (2, 3) min and 6 (5, 8) h respectively, intraoperative anhepatic phase was 80 (70, 100) min, intraoperative bleeding volume was 1 000 (550, 1 500) mL, and intraoperative blood transfusion volume was 1 200 (200, 1 600) mL. Postoperative TB, PTA, PT-INR and other indexes improved significantly compared to those preoperatively. Among the 51 patients, 10 cases died, with the death causes of multiple organ failure and severe infection(7 cases), renal insufficiency (2 cases), and cardiovascular complications (1 case). Survival rates at 1 month and 1 year post-transplantation for patients with severe liver disease were 82% and 80%, respectively. Cox regression analysis suggested that abnormal preoperative PTA and PT-INR were the risk factors for post-transplantation death in patients with severe liver disease.  Conclusions  Liver transplantation significantly improves the survival rate for patients with severe liver disease, perioperative infection prevention and treatment as well as multiple organ function management play key roles in improving post-transplantation survival rate in patients with severe liver disease.

     

    • FullText(HTML)
  • loading
    • References(24)
  • [1]
    OLSON JC. Acute-on-chronic and decompensated chronic liver failure: definitions, epidemiology, and prognostication[J]. Crit Care Clin, 2016, 32(3):301-309. DOI: 10.1016/j.ccc.2016.02.001.
    [2]
    SARIN SK, CHOUDHURY A. Management of acute-on-chronic liver failure: an algorithmic approach[J]. Hepatol Int, 2018, 12(5):402-416. DOI: 10.1007/s12072-018-9887-5.
    [3]
    SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update[J]. Hepatol Int, 2019, 13(4):353-390. DOI: 10.1007/s12072-019-09946-3.
    [4]
    BAJAJ JS. Hepatic encephalopathy: classification and treatment[J]. J Hepatol, 2018, 68(4):838-839. DOI: 10.1016/j.jhep.2017.11.005.
    [5]
    DURAND F, GRAUPERA I, GINÈS P, et al. Pathogenesis of hepatorenal syndrome: implications for therapy[J]. Am J Kidney Dis, 2016, 67(2):318-328. DOI: 10.1053/j.ajkd.2015.09.013.
    [6]
    CAI J, ZHANG M, HAN T, et al. Characteristics of infection and its impact on short-term outcome in patients with acute-on-chronic liver failure[J]. Medicine (Baltimore), 2017, 96(37):e8057. DOI: 10.1097/MD.0000000000008057.
    [7]
    JADLOWIEC CC, TANER T. Liver transplantation: current status and challenges[J]. World J Gastroenterol, 2016, 22(18):4438-4445. DOI: 10.3748/wjg.v22.i18.4438.
    [8]
    DURAND F. How to improve long-term outcome after liver transplantation?[J]. Liver Int, 2018, 38(Suppl 1):134-138. DOI: 10.1111/liv.13651.
    [9]
    RAO HB, PRAKASH A, SUDHINDRAN S, et al. Biliary strictures complicating living donor liver transplantation: problems, novel insights and solutions[J]. World J Gastroenterol, 2018, 24(19):2061-2072. DOI: 10.3748/wjg.v24.i19.2061.
    [10]
    REUBEN A, TILLMAN H, FONTANA RJ, et al. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study[J]. Ann Intern Med, 2016, 164(11):724-732. DOI: 10.7326/M15-2211.
    [11]
    MU J, CHEN Q, ZHU L, et al. Influence of gut microbiota and intestinal barrier on enterogenic infection after liver transplantation[J]. Curr Med Res Opin, 2019, 35(2):241-248. DOI: 10.1080/03007995.2018.1470085.
    [12]
    谈宜斌, 金学兰, 李源, 等.肝移植术后医院感染流行病学分析[J].中华器官移植杂志, 2018, 39(10):592-596. DOI: 10.3760/cma.j.issn.0254-1785.2018.10.004.

    TAN YB, JIN XL, LI Y, et al. Epidemiological study on nosocomial infection after liver transplantation[J]. Chin J Organ Transplant, 2018, 39(10):592-596. DOI: 10.3760/cma.j.issn.0254-1785.2018.10.004.
    [13]
    OLIVEIRA RA, TURRINI RNT, POVEDA VB. Risk factors for development of surgical site infections among liver transplantation recipients: an integrative literature review[J]. Am J Infect Control, 2018, 46(1):88-93. DOI: 10.1016/j.ajic.2017.05.021.
    [14]
    DHANASEKARAN R. Management of immunosuppression in liver transplantation[J]. Clin Liver Dis, 2017, 21(2):337-353. DOI: 10.1016/j.cld.2016.12.007.
    [15]
    BERNAL W, HYYRYLAINEN A, GERA A, et al. Lessons from look-back in acute liver failure? a single centre experience of 3 300 patients[J]. J Hepatol, 2013, 59(1):74-80. DOI: 10.1016/j.jhep.2013.02.010.
    [16]
    NADIM MK, GENYK YS, TOKIN C, et al. Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome[J]. Liver Transpl, 2012, 18(5):539-548. DOI: 10.1002/lt.23384.
    [17]
    RUIZ R, BARRI YM, JENNINGS LW, et al. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT)[J]. Liver Transpl, 2007, 13(6):838-843. doi: 10.1002/lt.21149
    [18]
    林潮双, 崇雨田, 杨林, 等.原位肝移植术前感染对预后的影响[J].中华医院感染学杂志, 2007, 17(10):1238-1239, 1291. DOI: 10.3321/j.issn:1005-4529.2007.10.019.

    LIN CS, CHONG YT, YANG L, et al. Impact of infection before orthotopic liver transplantation on prognosis[J]. Chin J Nosocomiol, 2007, 17(10):1238-1239, 1291. DOI: 10.3321/j.issn:1005-4529.2007.10.019.
    [19]
    NACIF LS, PINHEIRO RS, ROCHA-SANTOS V, et al. Better selection criteria with prognostic factors for liver transplantation[J]. Transplant Proc, 2018, 50(3):766-768. DOI: 10.1016/j.transproceed.2018.02.057.
    [20]
    SACLEUX SC, SAMUEL D. A critical review of MELD as a reliable tool for transplant prioritization[J]. Semin Liver Dis, 2019, 39(4):403-413. DOI: 10.1055/s-0039-1688750.
    [21]
    张茜, 侯梅华.血清CysC与hs-CRP对晚期肝硬化肝肾综合征患者的预测价值[J].肝脏, 2019, 24(8):959-961. DOI: 10.3969/j.issn.1008-1704.2019.08.041.

    ZHANG Q, HOU MH. Prediction value of serum CysC and hs-CRP in patients with liver and kidney syndrome in advanced cirrhosis[J]. Chin Hepatol, 2019, 24(8):959-961. DOI: 10.3969/j.issn.1008-1704.2019.08.041.
    [22]
    MAWATARI S, MORIUCHI A, OHBA F, et al. The recovery of the PT-INR to less than 1.3 predicts survival in patients with severe acute liver injury[J]. J Gastroenterol, 2018, 53(7):861-872. DOI: 10.1007/s00535-017-1421-3.
    [23]
    贾亚男, 李瀚, 李先亮, 等.危重症肝病肝移植患者诊断和评估标准的临床进展[J].器官移植, 2020, 11(3): 326-331, 368. DOI: 10.3969/j.issn.1674-7445.2020.03.002.

    JIA YN, LI H, LI XL, et al. Clinical progress of diagnostic and evaluation criteria for liver transplantation in patients with severe liver disease[J]. Organ Transplant, 2020, 11(3): 326-331, 368. DOI: 10.3969/j.issn.1674-7445.2020.03.002.
    [24]
    姚运海, 甘建和, 赵卫峰.4种评分系统对肝硬化合并感染患者预后的评估价值[J].临床肝胆病杂志, 2019, 35(1):87-91. DOI: 10.3969/j.issn.1001-5256.2019.01.016.

    YAO YH, GAN JH, ZHAO WF. Value of four scoring systems in evaluating the prognosis of cirrhotic patients with infection[J]. J Clin Hepatol, 2019, 35(1):87-91. DOI: 10.3969/j.issn.1001-5256.2019.01.016.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (185) PDF downloads(19) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return